日本全国多中心前瞻性研究:结肠胶囊内镜的实用性、安全性与可接受性
该研究在日本44家医院前瞻性纳入1006例接受第二代结肠胶囊内镜(CCE)检查的疑似或确诊结直肠疾病患者,评估全结肠检查完成率、肠道清洁充分率、结直肠息肉或肿瘤检出率、不良事件及可接受性。结果显示全结肠检查率为86.1%,总体肠道清洁充分率为65.5%,对≥6 mm和≥10 mm结直肠息肉或肿瘤患者的检出率分别为92%(95%CI 84-97)和89%(95%CI 78-96),胶囊滞留发生2例(0.20%),63%患者希望下次结肠镜检查选择CCE。结论认为在充分肠道准备下,CCE相对安全、耐受良好且对检出结直肠病变有用。
要点
- 全结肠检查率86.1%,总体肠道清洁充分率65.5%。
- 对≥6 mm和≥10 mm结直肠息肉或肿瘤患者的检出率分别为92%和89%。
- 胶囊滞留2例(0.20%),63%患者希望下次选择CCE。
核心结论
- 在充分肠道准备下,第二代结肠胶囊内镜(CCE)相对安全、耐受良好且对检出结直肠病变有用。
研究设计与样本
- 日本44家医院参加的前瞻性多中心研究,纳入1006例疑似或确诊结直肠疾病并接受CCE检查的患者。
- 临床试验注册号:UMIN000021936。
主要发现
- 全结肠检查率为86.1%。
- 总体肠道清洁充分率为65.5%。
- 对≥6 mm和≥10 mm结直肠息肉或肿瘤患者的检出率分别为92%(95%CI 84-97)和89%(95%CI 78-96)。
- 胶囊滞留发生2例(0.20%),需内镜和外科干预。
- 63%患者希望下次结肠镜检查选择CCE。
关键数值与推荐
- 全结肠检查的独立预测因素:年龄小于63岁(aOR 1.525)、男性(aOR 1.496)、炎症性肠病(aOR 1.889)、第-1天灌洗液摄入(aOR 1.625)、第0天灌洗液摄入≥1800 mL(aOR 0.595)、第0天促动力药(aOR 0.608)、第0天蓖麻油 booster ≥30 mL(aOR 1.734)。
- 肠道清洁充分的独立预测因素:便秘(aOR 0.527)、第-1天灌洗液摄入(aOR 1.822)、第-1天泻药摄入(aOR 2.616)、第0天灌洗液摄入≥1900 mL(aOR 1.449)。
- 检出≥6 mm结直肠息肉或肿瘤的独立预测因素:升结肠清洁不充分(aOR 0.184)、横结肠≥6 mm结直肠息肉或肿瘤(aOR 4.703)、左侧结肠≥6 mm结直肠息肉或肿瘤(aOR 32.013)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We determined the factors influencing total capsule colonoscopy, adequate cleansing, and detectability of second-generation colon capsule endoscopy (CCE) for colorectal polyps or tumors (CRTs), adverse events, and acceptability. METHODS: Among 44 Japanese hospitals, 1006 patients with suspected or documented colorectal diseases who underwent CCE were enrolled prospectively. RESULTS: The total capsule colonoscopy rate was 86.1%. Age younger than 63 years (adjusted odds ratio [aOR], 1.525), male sex (aOR, 1.496), inflammatory bowel disease (aOR, 1.889), lavage intake on day -1 (aOR, 1.625), ≥1800-mL lavage intake on day 0 (aOR, .595), prokinetics on day 0 (aOR, .608), and ≥30-mL castor oil booster on day 0 (aOR, 1.734) were significant independent predictors. The overall adequate cleansing rate was 65.5%. Constipation (aOR, .527), lavage intake on day -1 (aOR, 1.822), laxative intake on day -1 (aOR, 2.616), and ≥1900-mL lavage intake on day 0 (aOR, 1.449) were significant independent predictors. The detection rates for patients with CRTs ≥6 mm and ≥10 mm were 92% (95% confidence interval, 84-97) and 89% (95% confidence interval, 78-96), respectively. Inadequate cleansing in the ascending colon (aOR, .184), ≥6-mm CRT in the transverse colon (aOR, 4.703), and ≥6-mm CRT in the left-sided colon (aOR, 32.013) were significant independent predictors. CCE retention occurred in 2 patients (.20%) requiring endoscopic and surgical interventions. In total, 63% of patients desired CCE for their next colonoscopy. CONCLUSIONS: CCE was relatively safe, well tolerated, and useful for detecting colorectal lesions when adequate bowel preparation was made. (Clinical trial registration number: UMIN000021936.).
引用
- Hotta N, Ohmiya N, Hiraga H, et al. Nationwide multicenter prospective study on the usefulness, safety, and acceptability of colon capsule endoscopy in Japan. Gastrointest Endosc. 2024. PMID: 39521091. doi:10.1016/j.gie.2024.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。